Quick Answer
NIKA PHARMACEUTICALS, INC reported Shares Outstanding of 1.05 billion shares for fiscal year 2025.
NIKA PHARMACEUTICALS, INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.05B | +0.0% |
| 2024 | 1.05B | +19.6% |
| 2023 | 876.09M | +0.0% |
| 2022 | 876.09M | +121.2% |
| 2021 | 396.09M | +2900.0% |
| 2020 | 13.20M | +0.0% |
| 2019 | 13.20M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.04B | +2.1% | +1.3% |
| June 30, 2025 | 1.03B | +0.8% | +0.0% |
| March 31, 2025 | 1.03B | +17.2% | +17.2% |
| December 31, 2024 | 876.09M | +0.0% | -14.0% |
| September 30, 2024 | 1.02B | +16.3% | +0.0% |
| June 30, 2024 | 1.02B | +16.3% | +16.3% |
| March 31, 2024 | 876.09M | +0.0% | +0.0% |
| December 31, 2023 | 876.09M | +0.0% | +0.0% |
- NIKA PHARMACEUTICALS, INC showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, NIKA PHARMACEUTICALS, INC’s shares outstanding has grown by 7834.2% (from 13.20 million shares to 1.05 billion shares).
- The most recent figure is from NIKA PHARMACEUTICALS, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: